Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT00180934
Other study ID # JANORL
Secondary ID CSET 98/656
Status Active, not recruiting
Phase Phase 3
First received September 13, 2005
Last updated December 22, 2005
Start date July 1999

Study information

Verified date September 2005
Source Gustave Roussy, Cancer Campus, Grand Paris
Contact n/a
Is FDA regulated No
Health authority France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)
Study type Interventional

Clinical Trial Summary

Interest of a reirradiation with concomitant chemotherapy after salvage surgery for recurrence of head and cancer in irradiated area : a multicentric Phase III randomized trial


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 280
Est. completion date
Est. primary completion date
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- head and neck squamous cancer

- both sexes

- >=18 years

- recurrence treated by surgery and initially treated by radiotherapy

- with written informed consent at entry time

Exclusion Criteria:

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Diagnostic


Related Conditions & MeSH terms


Intervention

Procedure:
Reirradiation with concomitant chemotherapy


Locations

Country Name City State
France Institut Gustave Roussy Villejuif

Sponsors (1)

Lead Sponsor Collaborator
Gustave Roussy, Cancer Campus, Grand Paris

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Overall survival at 3 years
Secondary Local event-free survival
Secondary Toxicity